PCSK9

All (4) PCSK9 Inhibitors (3) PCSK9 Antagonists (1)

Catalog No.	Information	Product Use Citations
S8420	R-IMPP R-IMPP is an inhibitor of PCSK9 secretion, half maximal inhibitory concentration [IC50] = 4.8 μM.
S0118	SBC-110736 SBC-110736 is an inhibitor of proprotein convertase subtilisin kexin type 9 (PCSK9) that lowers cholesterol levels in mice.
E0116^New	PF-06446846 hydrochloride PF-06446846 (PF846) Hydrochloride is an orally bioavailable and specific inhibitor of PCSK9 with an IC50 of 0.3 µM in Huh7 cells.
S7976	SBC-115076 SBC-115076 is a potent extracellular proprotein convertase subtilisin kexin type 9 (PCSK9) antagonist.	Menopause, 2020, 27(10):1155-1166 Journal of Second Military Medical University, 2019, 40(4): 412-419 Molecules, 2018, 23(9)

Catalog No.

Information

Product Use Citations

Product Validations

S8420

R-IMPP is an inhibitor of PCSK9 secretion, half maximal inhibitory concentration [IC50] = 4.8 μM.

S0118

SBC-110736 is an inhibitor of proprotein convertase subtilisin kexin type 9 (PCSK9) that lowers cholesterol levels in mice.

E0116^New

PF-06446846 (PF846) Hydrochloride is an orally bioavailable and specific inhibitor of PCSK9 with an IC50 of 0.3 µM in Huh7 cells.

Catalog No.	Information	Product Use Citations	Product Validations
S7976	SBC-115076 SBC-115076 is a potent extracellular proprotein convertase subtilisin kexin type 9 (PCSK9) antagonist.	Menopause, 2020, 27(10):1155-1166 Journal of Second Military Medical University, 2019, 40(4): 412-419 Molecules, 2018, 23(9)

Catalog No.

Information

Product Use Citations

Product Validations

S7976